Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB - Imai, Masaki; Ito, Mutsumi; Kiso, Maki; Yamayoshi, Seiya; Uraki, Ryuta; Fukushi, Shuetsu; Watanabe, Shinji; Suzuki, Tadaki; Maeda, Ken; Sakai-Tagawa, Yuko; Iwatsuki-Horimoto, Kiyoko; Halfmann, Peter J.; et al. (The New England journal of medicine, 2023)
Keywords: Antiviral agents; Antiviral Agents - pharmacology; Antiviral Agents - therapeutic use; Coronavirus; Coronaviruses; Correspondence; COVID-19; COVID-19 - virology; COVID-19 Drug Treatment; Disease transmission; Drugs; FDA approval; Humans; Infectious Disease; Infectious diseases; Medical research; Monoclonal antibodies; R&D; Research & development; RNA polymerase; SARS-CoV-2 - drug effects; Severe acute respiratory syndrome coronavirus 2; Treatment Outcome; Viral Infections; Japan